Chargeurs (CRI) Investor Presentation summary
Event summary combining transcript, slides, and related documents.
Investor Presentation summary
13 Jun, 2025Strategic direction and shareholder structure
Groupe Familial Fribourg now controls over two-thirds of capital, supporting entrepreneurial development and long-term value creation.
Four world-leading, high-tech industrial assets with streamlined, modernized production facilities.
New operational and shareholder configuration marks a new chapter in value creation.
Business segments and portfolio
Operates in niche industrial and service markets, aiming for global leadership and supporting customer sustainability transitions.
Technologies division includes Advanced Materials (world leader in process films) and PCC Fashion Technologies (world leader in interlinings).
Luxury division features Museum Studio (cultural engineering), Luxury Fibers (traceable natural fibers), and premium personal accessories.
Brands like Novacel, Nativa, Cambridge Satchel, Swaine, and Altesse Studio target high-value, international clientele.
Financial and operational performance
Q1 2024 saw like-for-like revenue growth of 10%, with strong performance in both Technologies (+6.2%) and Luxury (+20.2%) divisions.
Americas and Asia contributed significantly to growth, with Asia's revenue share rising to 29%.
Museum Studio posted 34.9% growth, driven by major projects in the US, Middle East, and Europe.
Luxury Fibers and Personal Goods divisions benefited from selective marketing and new product launches.
Cilander acquisition project aims to strengthen high-end textile capabilities and aligns with the 2025-2030 strategic plan.
Latest events from Chargeurs
- Novacel sale and strategic refocus boost financial flexibility and target €1bn NAV by 2030.CRI
Q4 202519 Mar 2026 - Strong growth, strategic transformation, and all resolutions passed amid market and regulatory risks.CRI
AGM 202523 Dec 2025 - Strong Q3 growth in new businesses and luxury brands, with a robust outlook for 2026.CRI
Q3 20255 Nov 2025 - Stable H1 2025 revenue and NAV growth, strong Museum Studio, Novacel sale under review.CRI
Q2 202510 Sep 2025 - Q3 2024 revenue up 11.2% year-over-year, led by Novacel and Museum Studio growth.CRI
Q3 202413 Jun 2025 - Double-digit revenue growth and strong cashflow marked H1 2024, despite one-off costs.CRI
Q2 202413 Jun 2025 - Museum Studio and Personal Goods fueled 5.6% Q1 2025 revenue growth amid global headwinds.CRI
Q1 20256 Jun 2025 - Double-digit revenue growth, profit recovery, and strategic transformation marked 2024.CRI
Q4 20245 Jun 2025